David Parry

33.7k total citations · 7 hit papers
343 papers, 22.6k citations indexed

About

David Parry is a scholar working on Molecular Biology, Cell Biology and Biomaterials. According to data from OpenAlex, David Parry has authored 343 papers receiving a total of 22.6k indexed citations (citations by other indexed papers that have themselves been cited), including 149 papers in Molecular Biology, 135 papers in Cell Biology and 49 papers in Biomaterials. Recurrent topics in David Parry's work include Skin and Cellular Biology Research (98 papers), Hair Growth and Disorders (34 papers) and Silk-based biomaterials and applications (28 papers). David Parry is often cited by papers focused on Skin and Cellular Biology Research (98 papers), Hair Growth and Disorders (34 papers) and Silk-based biomaterials and applications (28 papers). David Parry collaborates with scholars based in New Zealand, United States and United Kingdom. David Parry's co-authors include Peter M. Steinert, Carolyn Cohen, Russell Fraser, A. S. Craig, John M. Squire, Gordon Peters, Lyuben N. Marekov, Emma Lees, James F. Conway and Godefridus J. Peters and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

David Parry

337 papers receiving 21.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16

1995 751 citations David Parry et al. profile →
α‐Helical coiled coils and bundles: How to design an α‐helical protein

1990 653 citations Carolyn Cohen, David Parry profile →
Regulation of p16^CDKN2 Expression and Its Implications for Cell Immortalization and Senescence

1996 622 citations David Parry et al. profile →
Raf-Induced Proliferation or Cell Cycle Arrest Is Determined by the Level of Raf Activity with Arrest Mediated by p21^Cip1

1997 578 citations David Parry, Emma Lees et al. profile →
New consensus nomenclature for mammalian keratins

2006 544 citations David Parry et al. profile →
A comparison of the size distribution of collagen fibrils in connective tissues as a function of age and a possible relation between fibril size distribution and mechanical properties

1978 445 citations David Parry, A. S. Craig et al. Proceedings of the Royal Society of London. Series B, Biological sciences profile →
Structural role of tropomyosin in muscle regulation: Analysis of the X-ray diffraction patterns from relaxed and contracting muscles

1973 431 citations David Parry, John M. Squire profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Parry New Zealand	83	11.4k	7.2k	3.6k	2.4k	1.9k	343	22.6k
Sabine Werner Switzerland	90	15.8k 1.4×	4.3k 0.6×	2.7k 0.7×	3.0k 1.2×	2.4k 1.3×	343	35.0k
Boris Hinz Canada	73	7.3k 0.6×	6.4k 0.9×	3.1k 0.9×	1.9k 0.8×	1.1k 0.6×	175	25.7k
Paul Börnstein United States	93	13.8k 1.2×	4.2k 0.6×	2.6k 0.7×	3.1k 1.3×	814 0.4×	277	27.2k
Benjamin Geiger Israel	102	18.8k 1.6×	23.8k 3.3×	3.7k 1.0×	2.6k 1.1×	1.2k 0.6×	342	43.4k
Reinhard Fässler Germany	109	16.5k 1.4×	13.0k 1.8×	3.5k 1.0×	1.1k 0.5×	714 0.4×	334	35.8k
Marian F. Young United States	75	10.0k 0.9×	4.2k 0.6×	2.3k 0.6×	1.3k 0.5×	2.6k 1.4×	247	22.2k
Dick Heinegård Sweden	90	11.2k 1.0×	9.9k 1.4×	2.3k 0.6×	1.4k 0.6×	873 0.5×	388	30.2k
Paul Martin United States	95	8.0k 0.7×	4.9k 0.7×	1.9k 0.5×	3.1k 1.3×	1.2k 0.6×	579	42.3k
George R. Martin United States	92	12.9k 1.1×	7.4k 1.0×	4.3k 1.2×	3.9k 1.6×	1.1k 0.6×	249	34.1k
Hynda K. Kleinman United States	102	16.4k 1.4×	8.3k 1.2×	6.3k 1.7×	4.0k 1.6×	953 0.5×	349	38.2k

Countries citing papers authored by David Parry

Since Specialization

Citations

This map shows the geographic impact of David Parry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Parry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Parry more than expected).

Fields of papers citing papers by David Parry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Parry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Parry. The network helps show where David Parry may publish in the future.

Co-authorship network of co-authors of David Parry

This figure shows the co-authorship network connecting the top 25 collaborators of David Parry. A scholar is included among the top collaborators of David Parry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Parry. David Parry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Khan, Tahir Naeem, Goutham Atla, David Parry, et al.. (2023). Regulatory de novo mutations underlying intellectual disability. Life Science Alliance. 6(5). e202201843–e202201843. 3 indexed citations

Huang, Longbin, et al.. (2022). Transforming engineering into ecological engineering for developing resilient ecosystems on mined landscapes. Mine closure. 29–48. 1 indexed citations

Barnes, Matthew J., et al.. (2022). An experimental model of contusion injury in humans. PLoS ONE. 17(11). e0277765–e0277765. 3 indexed citations

Tarnauskaitė, Žygimantė, Louise S. Bicknell, Joseph A. Marsh, et al.. (2019). Biallelic variants in DNA2 cause microcephalic primordial dwarfism. Human Mutation. 40(8). 1063–1070. 17 indexed citations

Leighton, Danielle, Judith Newton, David Parry, et al.. (2019). 15.33 Phenotype-genotype characterisation of ‘long survivors’ with motor neurone disease in Scotland. Journal of Neurology Neurosurgery & Psychiatry. 90(12). e5.2–e5.

Fraser, Russell & David Parry. (2017). Structural Transition of Trichocyte Keratin Intermediate Filaments During Development in the Hair Follicle. Sub-cellular biochemistry. 82. 131–149. 6 indexed citations

Baker, Paul J., Vasiliki Lagou, Isabelle Jéru, et al.. (2016). Familial Autoinflammation with Neutrophilic Dermatosis Reveals a Novel Regulatory Mechanism of Pyrin Activation. Cytokine. 46. 54–55. 1 indexed citations

Ledermann, Jonathan A., Philipp Harter, Charlie Gourley, et al.. (2016). Quality of life during olaparib maintenance therapy in platinum-sensitive relapsed serous ovarian cancer. UCL Discovery (University College London). 1 indexed citations

Smith, Adam B., Kim Cocks, Matthew Taylor, & David Parry. (2014). Most domains of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire C30 are reliable. Journal of Clinical Epidemiology. 67(8). 952–957. 12 indexed citations

10.

Schenk, Erin L., Brian D. Koh, Karen S. Flatten, et al.. (2012). Effects of Selective Checkpoint Kinase 1 Inhibition on Cytarabine Cytotoxicity in Acute Myelogenous Leukemia Cells In Vitro. Clinical Cancer Research. 18(19). 5364–5373. 43 indexed citations

11.

Chung, Injae, et al.. (2011). Preclinical Development of the Novel Chk1 Inhibitor SCH900776 in Combination with DNA-Damaging Agents and Antimetabolites. Molecular Cancer Therapeutics. 11(2). 427–438. 100 indexed citations

12.

Guzi, Timothy J., Kamil Paruch, Michael P. Dwyer, et al.. (2011). Targeting the Replication Checkpoint Using SCH 900776, a Potent and Functionally Selective CHK1 Inhibitor Identified via High Content Screening. Molecular Cancer Therapeutics. 10(4). 591–602. 135 indexed citations

13.

Parry, David, Clare V. Logan, Bruce E. Hayward, et al.. (2011). Mutations Causing Familial Biparental Hydatidiform Mole Implicate C6orf221 as a Possible Regulator of Genomic Imprinting in the Human Oocyte. The American Journal of Human Genetics. 89(3). 451–458. 174 indexed citations

14.

Parry, David, Timothy J. Guzi, Fergus Shanahan, et al.. (2010). Dinaciclib (SCH 727965), a Novel and Potent Cyclin-Dependent Kinase Inhibitor. Molecular Cancer Therapeutics. 9(8). 2344–2353. 434 indexed citations

15.

Smith, Thomasin A. & David Parry. (2006). Sequence analyses of Type I and Type II chains in human hair and epithelial keratin intermediate filaments: Promiscuous obligate heterodimers, Type II template for molecule formation and a rationale for heterodimer formation. Journal of Structural Biology. 158(3). 344–357. 11 indexed citations

16.

Squire, John M. & David Parry. (2005). Fibrous proteins : muscle and molecular motors. Elsevier eBooks. 4 indexed citations

17.

Korge, Bernhard, Henning Hamm, Heiko Traupe, et al.. (1999). Identification of Novel Mutations in Basic Hair Keratins hHb1 and hHb6 in Monilethrix: Implications for Protein Structure and Clinical Phenotype. Journal of Investigative Dermatology. 113(4). 607–612. 44 indexed citations

18.

Parry, David, James F. Conway, & Peter M. Steinert. (1986). Structural studies on lamin. Similarities and differences between lamin and intermediate-filament proteins. Biochemical Journal. 238(1). 305–308. 54 indexed citations

19.

Cohen, Carolyn & David Parry. (1986). α-Helical coiled coils — a widespread motif in proteins. Trends in Biochemical Sciences. 11(6). 245–248. 312 indexed citations

20.

Craig, A. S. & David Parry. (1981). Growth and development of collagen fibrils in immature tissues from rat and sheep. Proceedings of the Royal Society of London. Series B, Biological sciences. 212(1186). 85–92. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact